NewAmsterdam Pharma Company N.V. Warrant (NASDAQ: NAMSW) last traded at $12.65, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from NewAmsterdam Pharma Company N.V. Warrant’s own filings and are restated only when a new one is published.
NewAmsterdam Pharma Company N.V. Warrant trades on NASDAQ under the ticker NAMSW. Its market capitalisation is $1.51 billion.
Valuation measures for NewAmsterdam Pharma Company N.V. Warrant, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.51B |
|---|---|
| Enterprise value | $1.16B |
| Price / sales | 212.35 |
| Price / book | 2.39 |
| Beta | 0.76 |
Trailing-twelve-month figures tagged in NewAmsterdam Pharma Company N.V. Warrant's XBRL filings with the SEC.
| Revenue (TTM) | $7.12M |
|---|---|
| Net income (TTM) | -$259.50M |
| EPS (TTM) | -$2.15 |
| Operating margin | -3432.20% |
| Return on equity | -41.10% |
| Cash | $424.15M |
Range and volume for NAMSW over the past 52 weeks.
| 52-week high | $30.45 |
|---|---|
| 52-week low | $10.41 |
| Volume | 0 |
| Average volume | 2.7K |
| Previous close | $12.65 |
Invest a chosen dollar amount in NewAmsterdam Pharma Company N.V. Warrant with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NAMSW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.